Journal of Circulating Biomarkers launches “Special Issue titled The Biology and the Clinical Utility of Circulating Tumor Cells (CTCs)”

October 16, 2014

Open Access Journal of Circulating Biomarkers’ team announces the start of the Special Issue titled The Biology and the Clinical Utility of Circulating Tumor Cells (CTCs), pertaining to the journal’s domain.

Under the guest editorship of Ph.D. Dario Marchetti, Baylor College of Medicine, Houston (USA), this Special Issue will focus on detecting the latest findings in CTC research and clinical value. Contributions outlining accepted or novel CTC tests for better sensitivity and specificity are welcome, as well as biological and clinical approaches to present studies using mathematical models of cancer in the circulation, CTC technologies and methods for their detection, and clinical applications and experiences of applying CTC concepts to patient care.

Dario Marchetti, Ph.D., tumor and molecular biologist, is a tenured Professor in the Department of Pathology & Immunology with a joint appointment in the Department of Molecular & Cellular Biology at Baylor College of Medicine, and the director of the Circulating Tumor Cell (CTC) Core Facility at Baylor.

Dr. Marchetti is an internationally recognized authority in the field of CTCs to combat cancer metastasis for improved patient outcome. With keen insights into the biology of brain metastasis, he pioneered models for discoveries of molecular determinants underlying brain metastasis and biomarker properties of brain-homing CTCs. As a consummate scientist, Dr. Marchetti’s bibliography includes 145 publications of which 85 are in peer-reviewed journals in the fields of neuroscience and oncology. He has received numerous awards and secured uninterrupted funding for 25 years by receiving grants from federal, state, institutional and private Agencies. He is a reviewer for the most prominent journals in cancer research and sits on editorial boards of “Cancer Microenvironment, “Tumor Viruses”, “Vascular Cell”, "Clinical & Experimental Pathology", "International Journal of Oncology", “Cancer Letters”, “Journal of Cellular Biochemistry”, “Discovery/Discovery Reports” (a journal from Harvard Medical School) and "Cancer Metastasis Reviews" - among others. Dr. Marchetti is Editor-in-Chief of The Journal of Gene Therapy and acts as Guest Editor of the International Journal of Molecular Sciences (Basel, Switzerland) on brain metastasis. Further, he served/serves on grant reviewing panels of the National Institutes of Health of USA and Italy, the Department of Defense of the United States, and is frequently invited as grant reviewer and consultant for multiple national and international Agencies and Companies devoted to oncology research.

Dr. Marchetti graduated from the University of Pavia, Italy in 1979. He worked as a postdoctoral fellow at the University of Illinois, Chicago (1980-1982), University of Texas Medical Branch – Galveston (Texas) (1984-1986). He then became a research scientist at the University of Texas Health Science Center-Houston (1986-1991), Research Associate and later Instructor at UT MD Anderson Cancer Center (1992-1999), Assistant Professor at UT-Houston (1999-2001), and Associate Professor and later Professor (with tenure) at LSU-Baton Rouge, Louisiana (2002-2007), prior to joining the faculty at Baylor College of Medicine.

We invite experts from both industry and academia to submit their research papers to be peer-reviewed and included in the Special Issue. The deadline for all submissions is set to January 15, 2015; all accepted papers will be published in the Special Issue at no cost for the author.

For more information in regard to submissions and the Special Issue’s topics of interest, please click here.